Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role

This article was originally published in The Tan Sheet

Executive Summary

FDA's appointment of consumer advocate Peter Lurie to an Office of the Commissioner policy post suggests a strategy of bringing in some of the most outspoken critics of both the drug industry and FDA to address public perceptions of the agency

You may also be interested in...



FDA Strengthens Capitol Hill Muscle With Legislative Office Appointment

The appointment of House Energy and Commerce Committee staff veteran Jeanne Ireland to FDA's newly elevated legislation office further hones the agency's ability to influence lawmakers

FDA Report Calls For Dedicated Office Component For Dispute Management

FDA should create a unit within the commissioner's office dedicated to managing disputes between companies or other entities and the agency's centers, a report by agency staffers says

FDA Commissioner Must Not Come From Agency, Stupak Advises Obama

Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel